Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review.

Fexofenadine allergy antihistamines clinical trials drowsiness non-drowsy sedation

Journal

Current medical research and opinion
ISSN: 1473-4877
Titre abrégé: Curr Med Res Opin
Pays: England
ID NLM: 0351014

Informations de publication

Date de publication:
19 Jul 2024
Historique:
medline: 19 7 2024
pubmed: 19 7 2024
entrez: 19 7 2024
Statut: aheadofprint

Résumé

Fexofenadine is a second-generation inverse agonist of H We performed an electronic literature search using keywords such as fexofenadine, drowsiness, somnolence, sedation, fatigue, cognitive, impairment, psychomotor, driving performances, sleep, rapid eye movement, alertness, clinical study, Positron emission tomography (PET) and proportional impairment ratio (PIR) data along with other objective tests from various studies confirmed the non-sedative property of fexofenadine. Results of brain H Published literature based on various parameters and clinical trials conducted for evaluating the effect of fexofenadine on sedation and central nervous system shows fexofenadine is both clinically effective and non-sedating.

Identifiants

pubmed: 39028636
doi: 10.1080/03007995.2024.2378172
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-13

Auteurs

Ignacio J Ansotegui (IJ)

Department of Allergy & Immunology, Hospital Quirónsalud Bizkaia, Bilbao, Spain.

Jean Bousquet (J)

Institute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Freie Universität Berlin, Berlin, Germany.
Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Humboldt-Universität zu Berlin, Berlin, Germany.

Giorgio Walter Canonica (GW)

Personalized Medicine Asthma & Allergy Clinic, Humanitas University & Research Hospital, Milano, Italy.

Pascal Demolys (P)

Department of Pulmonology, Division of Allergy, University Hospital of Montpellier, Montpellier, France.
IDESP, University of Montpellier - INSERM, Montpellier, France.

Rene Maximiliano Gómez (RM)

Faculty of Health Sciences, Catholic University of Salta, Salta, Argentina.
Ayre Foundation/Alas Medical Institute, Salta, Argentina.

Eli O Meltzer (EO)

Department of Pediatrics, Division of Allergy and Immunology, University of California San Diego, La Jolla, CA, USA.

Margarita Murrieta-Aguttes (M)

Sanofi, Neuilly-sur-Seine, France.

Robert M Naclerio (RM)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, MD, USA.

Nelson Rosario Filho (N)

Department of Pediatrics, Federal University of Paraná, Paraná, Brazil.

Glenis K Scadding (GK)

RNENT Hospital, London, UK.
Department of Immunity & Infection, University College London, London, UK.

Classifications MeSH